James Kasuboski

James Kasuboski is a highly experienced professional in the fields of research and biotechnology, currently serving as Partner and Head of Research at Luma Group since January 2024. With a strong educational background, including a Ph.D. in Molecular & Cellular Biology from the University of Notre Dame and a B.S. in Biology from Hillsdale College, James has played significant roles in various organizations. These include positions as a Grant Reviewer for the DR RALPH AND MARIAN FALK MEDICAL RESEARCH TRUST, Advisor at the Chicago Biomedical Consortium, Mentor at Nucleate, Co-Founder and Board Member at Avilar Therapeutics, and SBIR/STTR Grant Reviewer for the National Cancer Institute. Additionally, James has contributed to several companies as a Board Member and Biotech Investor, demonstrating a commitment to advancing human health through science and innovation.